A Bioavailability Study of FL-101 in Healthy Male and Female Subjects

NCT04983732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: FL-101-Intravenous
DRUG: FL-101-Subcutaneous

Sponsor

Flame Biosciences